Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

Repligen Corporation (NASDAQ:RGEN) has announced that it has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands at Repligen's facilities in Waltham, MA and Lund, Sweden. Repligen is the main strategic supplier of Protein A ligands to Purolite, an emerging player in the Protein A resin market with its Praesto® line of modern agarose-based, high-flow chromatography resins. Pursuant to the agreement, Repligen will supply Protein A ligands to Purolite through November 2022, with an option for renewal through 2025. Protein A chromatography remains the gold standard for monoclonal antibody purification, consistently providing outstanding results.

Steve Tingley, VP of Sales for Repligen said, "We are delighted that Purolite has made the decision to extend our current supply agreement, which ensures the supply of high quality Protein A ligands to Purolite for the next five to eight years. This agreement is supported by Repligen's business continuity plans, quality systems and research and development expertise. We look forward to building on our relationship with Purolite, both as their primary Protein A ligand supplier and through the recently announced collaboration with Purolite on OPUS® pre-packed columns."

Chris Major, VP of Sales for Purolite, said "In 2015, we signed our first supply agreement with Repligen. They were a natural choice for us due to their reputation in the industry for quality and reliability, coupled with the fact they are the largest producer worldwide of Protein A ligands. Purolite has benefited from Repligen's unmatched expertise in ligand development and manufacturing, and their ability to provide dual site supply for critical raw materials, scalable manufacturing capacity and flexibility -- all of which are key considerations as we prepare to further penetrate the chromatography resin market. Today, our Praesto® resins continue to gain rapid traction in the industry and in response to customer requests, this extended agreement enhances our commitment to the security of supply of our highly competitive agarose-based Protein A resins."

Ends

Notes to editors

About Purolite Life Sciences

Since 1981, Purolite has been a trusted supplier of resin to the world’s most regulated industries. Through innovative R&D, Purolite Life Sciences has met the needs of tomorrow before they arrive. Today we offer a range of bioprocess scale high flow agarose resins for the purification of monoclonal antibodies and recombinant proteins. Our success is rooted in the quality and consistency of our products, working hand in hand with customers. With over 35 years of resin knowledge combined with our customer-focused approach and global manufacturing capacity, Purolite Life Sciences is committed to:

• Security of supply for agarose resins
• Regulatory and Quality
• Innovation – Jetted uniform particle size agarose

www.purolitelifesciences.com

Follow us on Twitter: @PuroliteLifeSci
Follow us on LinkedIn: Purolite Life Sciences

Media Contact:

Purolite Life Sciences
N: Marc Davies
E: [email protected]
T: (+44)1443 229334

More within